X

pharmaceutical industry India

Sai Life Sciences Reports Strong Q3 FY26 Growth with 27% Revenue Rise

Sai Life Sciences Limited (BSE: 544306, NSE: SAILIFE), a leading Indian Contract Research, Development and Manufacturing Organization (CRDMO), announced its…

Sequent Scientific (Viyash) reports higher revenue and margins in first merged-entity quarter

Sequent Scientific Limited (now Viyash Scientific Limited) (BSE: 512529 / NSE: SEQUENT) reported higher revenue and profitability in the quarter…